Kristina Lohmann

Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry

Thomas Berg, Uwe Naumann, Albrecht Stoehr et al. · Alimentary Pharmacology & Therapeutics · 2019 · 73 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Opportunities to Reduce Medication Regimen Complexity

Diana Witticke, Hanna M. Seidling, Kristina Lohmann et al. · Drug Safety · 2012 · 47 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +10

Safeguarding the process of drug administration with an emphasis on electronic support tools

Hanna M. Seidling, Anette Lampert, Kristina Lohmann et al. · British Journal of Clinical Pharmacology · 2013 · 23 citations · Full text

Computing, Health Informatics, Clinical Decision Support +11

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Heiner Wedemeyer, P. Erren, Uwe Naumann et al. · Liver International · 2021 · 18 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C‐Registry

Hartwig Klinker, Uwe Naumann, Martin Rössle et al. · Liver International · 2021 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17